Delhi HC restrains generic pharma firms from making, selling patent drug of Novartis

Delhi HC restrains generic pharma firms from making, selling patent drug of Novartis The injunction order has been passed against Natco Pharma, Torrent Pharmaceuticals, Eris Lifesciences and Windlas Biotech, generic pharma firms making or selling Valsartan and Sacubitril.

from Moneycontrol Business News https://ift.tt/3GKJNsf
Posted by: at
Tags:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Start-up Street: Social justice and the start-up ecosystem

Disparities in start-ups are a global phenomenon and affirmative action is needed to ensure an equal opportunities environment for aspiring...